Providing for consideration of the bill (H.R. 185) to advance responsible policies.
H. Res. 902 is a House rules resolution that sets up floor consideration of H.R. 185 and includes the text of the underlying substitute amendment, titled the “Bipartisan Healthcare Optimization, Protection, and Extension Act” or “HOPE Act.” The resolution waives certain points of order, deems the substitute adopted, limits debate to one hour, and provides for one motion to recommit. In practical terms, the resolution is procedural, but the incorporated legislative text would make substantive changes to federal health coverage rules.
The underlying bill would extend and modify enhanced Affordable Care Act premium tax credits for taxable years beginning after December 31, 2025, through 2027. It would preserve and expand subsidy eligibility by adjusting premium contribution percentages and allowing credits for households above 400 percent of the poverty line up to 935 percent of poverty. It also would require exchanges to notify individuals of the amount of their premium tax credit before enrollment, and it would extend the annual open enrollment period for plan year 2026 through May 15, 2026.
The bill also adds a series of anti-fraud and consumer-protection measures for ACA exchanges. It would impose new civil and criminal penalties on agents and brokers who provide false or fraudulent information, require verification and consent procedures for agent- or broker-assisted enrollments, regulate field marketing organizations and third-party marketing organizations, require audits and reporting of suspicious enrollment patterns, and direct the Secretary of Health and Human Services to share audit results with state insurance departments. In addition, it would require quarterly checks of the Death Master File to remove deceased individuals from exchange plans and set a preponderance-of-the-evidence standard for terminating certain agent or broker agreements.
The bill’s impact on state and federal law would be significant within the ACA marketplace framework. It amends sections of the Internal Revenue Code and the Patient Protection and Affordable Care Act, and it directs HHS to revise federal exchange regulations. While the bill is federal in scope, it also affects state insurance regulators and state-run or federally facilitated exchanges by creating new reporting, oversight, and coordination duties, especially regarding broker conduct, marketing organizations, fraud referrals, and enrollment verification.
No committee transcript or vote history was provided, so there is no recorded debate or roll-call sentiment in the materials supplied. Based on the text alone, the measure appears designed to appeal to both supporters of expanded premium assistance and advocates of stronger marketplace oversight. The main likely points of contention are the cost and scope of extending subsidies, the expansion of eligibility above 400 percent of poverty, and the new compliance burdens and penalties for brokers and marketing organizations versus the consumer-protection and anti-fraud rationale behind those provisions.
The resolution itself governs House procedure for considering H.R. 185, but the incorporated substitute would amend the Internal Revenue Code and the Affordable Care Act to extend enhanced premium tax credits, broaden subsidy eligibility, require exchange notice of credit amounts, lengthen open enrollment for 2026, and add new fraud-prevention, broker-regulation, and enrollment-verification requirements. It would also create new coordination and reporting responsibilities for exchanges, HHS, and state insurance departments, affecting agents, brokers, marketing organizations, insurers, and exchange enrollees.
No votes or committee discussion were provided, so there is no direct recorded sentiment. The bill’s title and structure suggest a bipartisan framing, and the policy mix combines consumer assistance with anti-fraud enforcement, which may attract support from lawmakers focused on affordability and marketplace integrity. At the same time, the expanded subsidy eligibility and regulatory requirements could draw criticism from those concerned about federal spending, administrative complexity, or increased compliance burdens.
The most likely points of contention are the extension of enhanced premium tax credits beyond 2025, especially the expansion of eligibility above 400 percent of poverty up to 935 percent, and whether the subsidy structure is too costly or too generous. Another area of debate is the new regulatory regime for agents, brokers, field marketing organizations, and third-party marketing organizations, including civil and criminal penalties, audit authority, and marketing restrictions. Supporters are likely to emphasize consumer protection, fraud reduction, and continuity of coverage, while critics may argue the bill imposes heavy federal oversight and could disrupt existing enrollment and brokerage practices.